MedTrace Logo

oncoFISH Cervical Test for Detection of 3q26 Region Gain

NCT01416922 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2011-08-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of the oncoFISH cervical test system in the management of women who have received an LSIL Pap report to determine whether the test can predict which women will progress to more serious cervical disease and which women do not have to be monitored as closely.

Conditions

Sponsors & Collaborators

  • Ikonisys, Inc.

    lead INDUSTRY

Principal Investigators

  • Michael W Kilpatrick, Ph.D. · Ikonisys, Inc.

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416922 on ClinicalTrials.gov